http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 25 Jul 2024 16:46:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Press+Releases/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html <p align="justify"><strong>BAYTOWN, TX, July 25, 2024 (GLOBE NEWSWIRE) -- </strong>Sagaliam Acquisition Corp (Expert Market: SAGA) (the “Company”) announced today that it believes that a misleading press release has been issued by Nika Pharmaceuticals, Inc. in another attempt by NIKA and its CEO, Dimtar Savov, to falsely claim rights to patents issued to Harry H. Zhabilov and the Zhabilov Trust for the Immunotherapy treatment of HIV/AIDS. Mr. Savov has erroneously and maliciously asserted claims to ITV-1 in attempts to mislead the investing public and to harm the shareholder value of SAGA as well as the former owner, Enzolytics, Inc. http://www.streetinsider.com/Globe+Newswire/SAGALIUM+RESPONDS+TO+COMPETITOR%E2%80%99S+FALSE+AND+MISLEADING+PRESS+RELEASE/23506857.html Thu, 25 Jul 2024 16:46:00 -0400 A.50114226 ENZC O.06574698 O.54217469 SAGA